SCHEMBL7101375

SCHEMBL7101375

Nc1nc2c(ncn2[C@@H]2O[C@H](CO)C(O)(O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.53
▸ HINT1 P49773 4/20 0.51
▸ HPGD P15428 2/20 0.51
▸ NT5E P21589 1/20 0.51
▸ STING1 Q86WV6 2/20 0.50
▸ PDE3B Q13370 1/20 0.50
▸ PDE3A Q14432 1/20 0.50
▸ GSK3A P49840 2/20 0.48
▸ RPS6KA3 P51812 2/20 0.48
▸ MAPK14 Q16539 2/20 0.48
▸ TGM2 P21980 1/20 0.47
▸ TAAR1 Q96RJ0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29908542 0.90 ADORA3 (0.52) ADORA3HINT1HPGDNT5ESTING1
SCHEMBL12151803 0.89 HINT1 (0.52) ADORA3HINT1HPGDNT5ESTING1
SCHEMBL1374868 0.89 HINT1 (0.52) ADORA3HINT1HPGDNT5ESTING1
SCHEMBL12758342 0.89 HINT1 (0.52) ADORA3HINT1HPGDNT5ESTING1
SCHEMBL3734057 0.89 ADORA3 (0.51) ADORA3HINT1HPGDNT5ESTING1
SCHEMBL3427138 0.89 ADORA3 (0.50) ADORA3HINT1HPGDNT5ESTING1
SCHEMBL18490626 0.88 ADORA3 (0.52) ADORA3HINT1HPGDNT5ESTING1
SCHEMBL28911222 0.88 HPGD (0.54) ADORA3HINT1HPGDNT5ESTING1
SCHEMBL3437184 0.87 NT5E (0.51) ADORA3HINT1HPGDNT5ESTING1
SCHEMBL29771263 0.87 HINT1 (0.51) ADORA3HINT1HPGDNT5ESTING1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025217126-A1 POLYNUCLEOTIDES, 3' CHAIN TERMINATING TAILS, LIGATION AND USES THEREOF CONVERGENCE BIO, INC. (US) 2025-10-16 — — WO disclosed
US-20030040114-A1 SMALL MOLECULE MODULATION OF RIBOZYMES WARNER-LAMBERT COMPANY, 2003-02-27 — — US disclosed
Send feedback